ClinicalTrials.Veeva

Menu

Tertiary Prevention of Child Sexual Abuse

University of Minnesota (UMN) logo

University of Minnesota (UMN)

Status

Completed

Conditions

Child Sexual Abuse

Treatments

Other: Treatment as usual
Behavioral: group therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT06126926
FMCH-2023-32331

Details and patient eligibility

About

This is a feasibility study designed to inform the development of a multinational study of the effectiveness of a tertiary prevention program for child sexual abuse. This study targets adult men who have engaged in child sexual abuse, and will be implemented within the Minnesota Department of Corrections. Data will include measures of the implementation process, short-terms changes in criminogenic factors, and staff and participant factors that could influence outcomes.

Enrollment

10 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male
  • 18 or older
  • Serving time in MnDOC facilities for Criminal Sexual Conduct in the first, second, or third degree, whose victims were less than 14 years old
  • Individuals assigned moderate to high risk to reoffend as determined upon entrance to the Minnesota Correctional System by the DOC Risk Assessment/Community Notification Unit."

Exclusion criteria

  • Diagnosed with an active, uncontrolled major mental disorder (e.g. bi-polar, schizophrenia, schizoaffective disorder, major depression with psychotic features)
  • Unable to read English at the 5th grade level
  • Unable to speak English
  • IQ of less than 85 as measured by standard intelligence tests
  • Diagnosis of intellectual disability
  • Engaged in violent behavior while incarcerated, as indicated by disciplinary actions and/or segregation within 60 days of intake"

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

None (Open label)

10 participants in 2 patient groups

Intervention arm
Experimental group
Description:
32-week group therapy
Treatment:
Behavioral: group therapy
Control group
Active Comparator group
Description:
Treatment as Usual
Treatment:
Other: Treatment as usual

Trial contacts and locations

1

Loading...

Central trial contact

Alexandra Hanson

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems